Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,038 | -29,719 | -17,412 | -150,660 | -142,777 |
| Depreciation Amortization | -3,608 | -255 | 51 | 2,162 | 1,810 |
| Income taxes - deferred | 1,125 | 448 | 242 | -3,283 | 2,318 |
| Accounts receivable | 2,397 | -693 | 8,599 | -7,420 | -3,058 |
| Accounts payable and accrued liabilities | -8,261 | N/A | -7,912 | N/A | -178 |
| Other Working Capital | -15,817 | -12,070 | -5,866 | 36,476 | 20,588 |
| Other Operating Activity | 7,969 | -15,052 | -7,210 | 46,738 | 57,394 |
| Operating Cash Flow | $-81,233 | $-57,341 | $-29,508 | $-75,987 | $-63,903 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -23,849 | -35,556 | -8,832 | 89,108 | 98,154 |
| PPE Investments | -609 | -483 | -514 | -6,514 | -6,030 |
| Other Investing Activity | 0 | 0 | 0 | 7,966 | 0 |
| Investing Cash Flow | $-24,458 | $-36,039 | $-9,346 | $90,560 | $92,124 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 68,000 | 68,000 | 34,000 | N/A | N/A |
| Other Financing Activity | -7,911 | -5,559 | -2,494 | -693 | 118 |
| Financing Cash Flow | $60,089 | $62,441 | $31,506 | $-693 | $118 |
| Exchange Rate Effect | 647 | 788 | 411 | -1,419 | -3,500 |
| Beginning Cash Position | 72,639 | 72,639 | 72,639 | 60,178 | 60,178 |
| End Cash Position | 27,684 | 42,488 | 65,702 | 72,639 | 85,017 |
| Net Cash Flow | $-44,955 | $-30,151 | $-6,937 | $12,461 | $24,839 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,233 | -57,341 | -29,508 | -75,987 | -63,903 |
| Capital Expenditure | -609 | -483 | -514 | -6,514 | -6,030 |
| Free Cash Flow | -81,842 | -57,824 | -30,022 | -82,501 | -69,933 |